A Pilot Study, efficacy and safety of Ruxolitinib in treating steroids resistant Cytokine-release-syndrome during Car T Therapy
Latest Information Update: 17 Jul 2020
At a glance
- Drugs Ruxolitinib (Primary) ; Steroids
- Indications Cytokine release syndrome
- Focus Adverse reactions; Therapeutic Use
- 17 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association